Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?

OBJECTIVE: Organ transplant recipients receive immunosuppressive regimens to prevent transplant rejection, which put them at increased risk for opportunistic infections like cytomegalovirus (CMV). Ganciclovir and Valganciclovir are mostly used to prevent or treat CMV. Any incorrect use of the drug m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Transplant
Main Authors: Mozaffar, Maryam, Shahidi, Shahrzad, Mansourian, Marjan, Badri, Shirinsadat
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6167560/
https://ncbi.nlm.nih.gov/pubmed/30319817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8414385
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares